TLTE4 - Overview: Leukotriene E4, 24 Hour, Urine
Aiding in the evaluation of patients at-risk for mast cell activation syndrome (eg, systemic mastocytosis, IgE-mediated allergies, or aspirin-exacerbated respiratory disease) using 24-hour urine collections
INFXR - Overview: Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum
Trough level quantitation for evaluation of patients undergoing therapy with infliximab, with signs and symptoms of loss of response to therapy.
HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation
Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood
23FBG - Overview: Fibroblast Growth Factor-23 (FGF23), In Situ Hybridization
Assessing fibroblast growth factor-23 (FGF23) expression
PHU_ - Overview: pH, Random, Urine
Assessment of patients with metabolic acidosis Assessment of crystalluria Monitoring the effectiveness of alkalinization or acidification of urine for certain medical conditions (eg, treatment of uric acid nephrolithiasis)
LEU - Overview: Fecal Leukocytes, Feces
Suggesting the presence of pathogens such as Salmonella, Shigella, and amebiasis
OXYMU - Overview: Oxymorphone Confirmation, Random, Urine
Detection and quantification of oxymorphone and noroxymorphone in urine
FLEC - Overview: Flecainide, Serum
Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance
STPCO - Overview: ThinPrep with Human Papillomavirus (HPV) Co-Test-Screen, Varies
Screening for cervical carcinoma or intraepithelial lesions and the presence or absence of high-risk human papillomavirus (HR-HPV) when screening women over the age of 30 for possible cervical neoplasia Detection of high-risk HPV genotypes...
NSFIB - Overview: Nonalcoholic Steatohepatitis (NASH)-FibroTest, Serum and Plasma
Diagnosis and the follow-up of liver fibrosis, steatosis, and inflammation Estimating hepatic fibrosis Assessing inflammation for metabolic diseases Assessing severity of nonalcoholic steatohepatitis (NASH) in patients with...